Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001218609 | SCV001390497 | uncertain significance | Early myoclonic encephalopathy | 2019-06-24 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals with JMJD1C-related conditions. This sequence change replaces arginine with cysteine at codon 1738 of the JMJD1C protein (p.Arg1738Cys). The arginine residue is highly conserved and there is a large physicochemical difference between arginine and cysteine. This variant is present in population databases (rs770904355, ExAC 0.006%). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C15"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |